The Use of Vitamin C for Prophylaxis and Management of COVID-19 in G6PD Deficiency; A Case Report in Nigeria
Keywords:
COVID-19, Ascorbic acid, Garcinia kola, Glucose-6-phosphate dehydrogenase, Acute Haemolytic AnaemiaAbstract
The rationale behind this case report is to identify some adverse effects, if any, in the use of vitamin C (ascorbic acid) by those living with Glucose-6-phosphate dehydrogenase (G6PD) deficiency, an enzymopathy affecting about 400 million people globally. The study was done to ascertain the prophylactic efficacy of ascorbic acid among Nigerians towards contacting COVID-19. There was a case of a G6PD deficient caregiver who agreed for the use of the information voluntarily provided based on his experience in the use of vitamin C between March 15, 2020, and October 30, 2020. The only time the subject had heartburn, it was quelled using vitamin C enriched fruits. The caregiver experience as a deficient patient of Glucose-6-phosphate dehydrogenase and the use of Vitamin C for COVID-19 prophylaxis without any serious contraindication shows that vitamin C is equally very good in the prophylaxis and management of COVID-19 in G6PD deficient subjects.
Downloads
Published
Issue
Section
Categories
License
All articles in JCBR are published under CC BY 4.0. Authors retain copyright of their articles. The Journal of Current Biomedical Research (JCBR) publishes all articles under the Creative Commons Attribution 4.0 International license (CC BY 4.0). This license permits use, sharing, adaptation, distribution, and reproduction in any medium or format, for any purpose, provided appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any changes are indicated. The Version of Record should be cited with its DOI.
License: https://creativecommons.org/licenses/by/4.0/
